{"nct_id":"NCT02917993","title":"An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2016-12-20","start_date_type":"ACTUAL","primary_completion_date":"2025-12-31","primary_completion_date_type":"ESTIMATED","completion_date":"2025-12-31","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["INCY"]}